Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Athos Bousvaros"'
Autor:
Yanjia Jason Zhang, Athos Bousvaros, Michael Docktor, Abby L. Kaplan, Paul A. Rufo, McKenzie Leier, Madison Weatherly, Lori Zimmerman, Le Thanh Tu Nguyen, Brenda Barton, George Russell, Eric J. Alm, Stacy A. Kahn
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Fecal Microbiota Transplant (FMT) has shown some success in treating inflammatory bowel diseases (IBD). There is emerging evidence that host engraftment of donor taxa is a tenet of successful FMT. We undertook a double-blind, randomized, pla
Externí odkaz:
https://doaj.org/article/eff6710f034e477a8e78cd9b4e399eff
Autor:
Nathan P Palmer, Jocelyn A Silvester, Jessica J Lee, Andrew L Beam, Inbar Fried, Vladimir I Valtchinov, Fedik Rahimov, Sek Won Kong, Saum Ghodoussipour, Helen C Hood, Athos Bousvaros, Richard J Grand, Louis M Kunkel, Isaac S Kohane
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0222952 (2019)
BackgroundPresenting features of inflammatory bowel disease (IBD) are non-specific. We hypothesized that mRNA profiles could (1) identify genes and pathways involved in disease pathogenesis; (2) identify a molecular signature that differentiates IBD
Externí odkaz:
https://doaj.org/article/9fb54ecdb5224005bb2588996be46f10
Autor:
Sigrid Bairdain, Moti Freiman, Jeanette M P and eacute;rez-Rossell and oacute;, Michael J Callahan, Athos Bousvaros, Simon K Warfield, Bradley C Linden
Publikováno v:
Archives of Clinical and Experimental Surgery, Vol 5, Iss 2, Pp 116-120 (2016)
Crohn disease is a chronic inflammatory bowel disease of unknown etiology with approximately one-third of patients being children and adolescents. Long-standing inflammation can result in fibrostenosing disease, usually of the terminal ileum. However
Externí odkaz:
https://doaj.org/article/4c107b2c3c9748c4911dc4bee7d4113a
Autor:
Naamah L Zitomersky, Benjamin J Atkinson, Sarah W Franklin, Paul D Mitchell, Scott B Snapper, Laurie E Comstock, Athos Bousvaros
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e63686 (2013)
There is extensive evidence implicating the intestinal microbiota in inflammatory bowel disease [IBD], but no microbial agent has been identified as a sole causative agent. Bacteroidales are numerically dominant intestinal organisms that associate wi
Externí odkaz:
https://doaj.org/article/dd7c33b2592d446091bd9be0c53ad9f8
Autor:
Eliseo Papa, Michael Docktor, Christopher Smillie, Sarah Weber, Sarah P Preheim, Dirk Gevers, Georgia Giannoukos, Dawn Ciulla, Diana Tabbaa, Jay Ingram, David B Schauer, Doyle V Ward, Joshua R Korzenik, Ramnik J Xavier, Athos Bousvaros, Eric J Alm
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e39242 (2012)
BACKGROUND:Pediatric inflammatory bowel disease (IBD) is challenging to diagnose because of the non-specificity of symptoms; an unequivocal diagnosis can only be made using colonoscopy, which clinicians are reluctant to recommend for children. Diagno
Externí odkaz:
https://doaj.org/article/dbee976b36a54737ac2c5bf0d90ea952
Autor:
Stacy A. Kahn, Athos Bousvaros
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 76:407-409
Autor:
Stacy A, Kahn, Athos, Bousvaros
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 75:418-422
Increasingly, in the United States, the prescribing of high-cost drugs has become a challenge for physicians and other practitioners. Such drugs are highly regulated by third-party payers (aka insurance), as well as pharmacy benefit managers. Not inf
Autor:
Lori A Zimmerman, Jonathan Spaan, Nathan Weinbren, Krishanth Manokaran, Aravindh Ajithkumar, Anna Bogursky, Enju Liu, Craig Lillehei, Brent R Weil, Jill M Zalieckas, Athos Bousvaros, Paul A Rufo
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition.
Publikováno v:
Journal of pediatric gastroenterology and nutrition.
Sulfasalazine is commonly used to treat pediatric ulcerative colitis (UC). Sulfasalazine can be compounded into a suspension form which is beneficial for children with difficulty swallowing a pill. Despite being utilized for over 40 years, there is a
Autor:
Anne M. Griffiths, Anat Horesh, Liron Marcovitch, Anthony R. Otley, David R. Mack, Dan Turner, Amy E. Hale, Adi Shosberger, G Focht, Michael D. Kappelman, Robert Baldassano, Jeffrey S. Hyams, Athos Bousvaros
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition.
As part of the development of the TUMMY-UC, a patient-reported outcome (PRO) measure for pediatric ulcerative colitis (UC), we aimed to explore agreement on UC symptoms between children and their caregivers. We conducted 44 interviews with children a